Money · Federal contracts
NOVARTIS PHARMACEUTICALS CORPORATION
$8,397,012.62 in contract dollars, fiscal year 2027Confirmed from the official record
- Unique Entity ID (UEI)
- NG61ZA8TADW3
- Parent company
- NOVARTIS PHARMACEUTICALS CORPORATION (this vendor is its own parent)
- Registered address
- EAST HANOVER, NJ, district NJ-11
- Other names on record
- NOVARTIS PHARMACEUTICALS CORP.
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved October 14, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027: $8,397,012.62
| Agency | Contract dollars |
|---|---|
| Department of Veterans Affairs | $8,397,012.62 |
| District where the work is done | Contract dollars |
|---|---|
| NJ-11Analilia Mejia | $8,350,733.42 |
| GA-12Rick W. Allen | $46,279.20 |
Fiscal year 2026: $39,879,682.35
| Agency | Contract dollars |
|---|---|
| Department of Veterans Affairs | $37,915,961.79 |
| Department of Defense | $4,459,696.86 |
| Department of Justice | $43,519.93 |
| Department of Health and Human Services | -$2,539,496.23 |
| District where the work is done | Contract dollars |
|---|---|
| NJ-11Analilia Mejia | $20,719,684.97 |
| CA-32Brad Sherman | $3,914,027.60 |
| TX-21Chip Roy | $3,232,079.59 |
| CT-03Rosa L. DeLauro | $2,949,306.36 |
| PA-09Daniel Meuser | $1,980,570.88 |
| CA-06Ami Bera | $1,200,299.10 |
| MO-02Ann Wagner | $1,028,827.80 |
| AZ-03Yassamin Ansari | $1,023,070.80 |
| MO-01Wesley Bell | $891,650.76 |
| CA-50Scott H. Peters | $823,062.24 |
| AZ-01David Schweikert | $623,053.68 |
| MD-08Jamie Raskin | $578,754.32 |
| NC-02Deborah K. Ross | $389,151.01 |
| IL-07Danny K. Davis | $365,520.54 |
| FL-07Cory Mills | $160,622.70 |
| GA-12Rick W. Allen | $0 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| HHSO100201700026CELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF | Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | EAST HANOVER, NJ-11 | $16,334,774.81 | Ends May 22, 2026 |
| 36C24826F0082PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $4,732,607.88 | Ends August 31, 2026 |
| 36C26226N0112PLUVICTO AND LUTATHERA | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $4,299,446.99 | Ends October 31, 2026 |
| 36C25726N0205LU177 - PLUVICTO/LUTATHERA | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $4,162,659.22 | Ends February 6, 2027 |
| 36C26127N0063PLUVICTO NDC: 69488-0010-61 | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $4,115,311.20 | Ends September 30, 2027 |
| 36C26126F0007PLUVICTO DRUG | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $3,987,496.80 | Ends September 30, 2026 |
| W81K0025FA195LUTATHERA AND PLUVICTO | Department of DefenseDepartment of the Army | SAN ANTONIO, TX-21 | $3,232,079.59 | Ends September 30, 2026 |
| 36C25725N0190LUTATHERA & PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $2,669,628.50 | Ends February 6, 2026 |
| 36C24126F0136PLUVICTO | Department of Veterans Affairs | WEST HAVEN, CT-03 | $2,537,775.24 | Ends September 29, 2027 |
| 36C25026N0310RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $2,423,132.82 | Ends December 31, 2026 |
| 36C24426F0063RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS | Department of Veterans Affairs | LEBANON, PA-09 | $1,980,570.88 | Ends December 31, 2026 |
| 36C26127N0055PLUVCITO NDC: 69488-0010-61 | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,851,890.04 | Ends September 30, 2027 |
| 36C25525N0396PLUVICTO | Department of Veterans Affairs | SAINT LOUIS, MO-02 | $1,765,437.80 | Ends July 31, 2026 |
| 36C25225F0191DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO. | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,733,030.46 | Ends August 31, 2027 |
| 36C26226F0048PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML) | Department of Veterans Affairs | PHOENIX, AZ-01 | $1,646,124.48 | Ends January 1, 2027 |
| 36C26126F0017PLUVICTO FY26 | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,630,147.68 | Ends September 30, 2026 |
| 36C26126F0008LUTATHERA CANCER THERAPY | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,348,841.44 | Ends September 30, 2027 |
| 36C25027N0038PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,303,181.88 | Ends September 30, 2027 |
| 36C26126F0168PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML | Department of Veterans Affairs | MATHER, CA-06 | $1,200,299.10 | Ends September 30, 2026 |
| 36C25026N0006PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $1,163,019.90 | Ends September 30, 2026 |
| 36C25526N0394PLUVICTO SUPPLIES | Department of Veterans Affairs | SAINT LOUIS, MO-01 | $891,650.76 | Ends February 5, 2027 |
| 36C25725N0376PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $857,356.50 | Ends June 30, 2027 |
| 36C26226F0314PLUVICTO DELIVERY ORDER | Department of Veterans Affairs | SAN DIEGO, CA-50 | $823,062.24 | Ends December 31, 2026 |
| 36C25226N0246PLUVICTO | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $823,062.24 | Ends September 30, 2026 |
| 36C24226N0216PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML) | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $813,476.16 | Ends October 31, 2026 |
| 36C24125F0148PLUVICTO | Department of Veterans Affairs | WEST HAVEN, CT-03 | $810,280.80 | Ends March 14, 2027 |
| 36C25026N041626AP2812 - PLUVICTO - CLEVELAND VAMC | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $617,296.68 | Ends December 31, 2026 |
| 36C25026F0205PLUVICTO 2026 - CLEVELAND VAMC | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $617,296.68 | Ends June 30, 2026 |
| HT001426PE027ACQUISITION OF PLUVICTO AND LUTATHERA FOR RADIOLOGY PATIENTS. | Department of DefenseDefense Health Agency | BETHESDA, MD-08 | $578,754.32 | Ends January 15, 2026 |
| 36C25026F0204PLUVICTO 2026 CLEVELAND | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $501,669.60 | Ends December 31, 2026 |
| 36C25226F0037PLUVICTO RADIOPHARMACEUTICAL | Department of Veterans Affairs | CHICAGO, IL-07 | $365,520.54 | Ends January 31, 2026 |
| 36C25026N0254RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $316,159.88 | Ends January 31, 2026 |
| HT941026FE013PLUVICTO AND LUTATHERA INJECTIONS | Department of DefenseDefense Health Agency | EAST HANOVER, NJ-11 | $275,812.41 | Ends January 2, 2026 |
| 36C26127F0023LUTATHERA LU 177 DOTATE | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $250,834.80 | Ends September 30, 2027 |
| HT941026FE027PLUVICTO AND LUTATHERA INJECTION | Department of DefenseDefense Health Agency | EAST HANOVER, NJ-11 | $205,765.56 | Ends September 30, 2026 |
| 36C24826N0026GA-68 DOTATATE (NETSPOT) | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $171,859.50 | Ends September 30, 2026 |
| 36C25225N0482LUTATHERA - LUTETIUM LU 177 DOTATATE | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $169,296.17 | Ends August 26, 2026 |
| HT941026FE065PLUVICTO AND LUTATHERA INJECTIONS | Department of DefenseDefense Health Agency | EAST HANOVER, NJ-11 | $167,284.98 | Ends September 30, 2026 |
| 36C24827N0026NETSPOT - GA-68 DOTATATE | Department of Veterans Affairs | EAST HANOVER, NJ-11 | $160,622.70 | Ends September 30, 2027 |
| 36C26226N0271VA GLA NETSPOT | Department of Veterans Affairs | LAKE MARY, FL-07 | $160,622.70 | Ends December 31, 2026 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
No lobbying report, organization page or FEC receipt in our saved records has this vendor’s name or its parent company’s name.
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.